BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 27356690)

  • 1. Matrix Metalloproteinase-13 - A Potential Biomarker for Detection and Prognostic Assessment of Patients with Esophageal Squamous Cell Carcinoma.
    Sedighi M; Aledavood SA; Abbaszadegan M; Memar B; Montazer M; Rajabian M; Gholamin M
    Asian Pac J Cancer Prev; 2016; 17(6):2781-5. PubMed ID: 27356690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical significance of serum matrix metalloproteinase-13 levels in patients with esophageal squamous cell carcinoma (ESCC).
    Jiao XL; Chen D; Wang JG; Zhang KJ
    Eur Rev Med Pharmacol Sci; 2014; 18(4):509-15. PubMed ID: 24610617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating levels of autoantibodies against L1-cell adhesion molecule as a potential diagnostic biomarker in esophageal squamous cell carcinoma.
    Xu YW; Peng YH; Ran LQ; Zhai TT; Guo HP; Qiu SQ; Chen HL; Wu ZY; Li EM; Xie JJ
    Clin Transl Oncol; 2017 Jul; 19(7):898-906. PubMed ID: 28181176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokeratin 15 is an Effective Indicator for Progression and Malignancy of Esophageal Squamous Cell Carcinomas.
    Shen YH; Xu CP; Shi ZM; Zhang YJ; Qiao YG; Zhao HP
    Asian Pac J Cancer Prev; 2016; 17(9):4217-4222. PubMed ID: 27797221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical significance of the detection of thymidine phosphorylase activity in esophageal squamous cell carcinomas.
    Ikeguchi M; Oka S; Saito H; Kondo A; Tsujitani S; Maeta M; Kaibara N
    Eur Surg Res; 1999; 31(4):357-63. PubMed ID: 10449995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating Anti-Matrix Metalloproteinase-7 Antibodies May Be a Potential Biomarker for Oral Squamous Cell Carcinoma.
    Jiang T; Xie P; Liu H
    J Oral Maxillofac Surg; 2016 Mar; 74(3):650-7. PubMed ID: 26454036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of lysyl oxidase is correlated with lymph node metastasis and poor prognosis in esophageal squamous cell carcinoma.
    Sakai M; Kato H; Sano A; Tanaka N; Inose T; Kimura H; Sohda M; Nakajima M; Kuwano H
    Ann Surg Oncol; 2009 Sep; 16(9):2494-501. PubMed ID: 19526206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p12CDK2-AP1 is associated with tumor progression and a poor prognosis in esophageal squamous cell carcinoma.
    Hiyoshi Y; Watanabe M; Hirashima K; Karashima R; Sato N; Imamura Y; Nagai Y; Yoshida N; Toyama E; Hayashi N; Baba H
    Oncol Rep; 2009 Jul; 22(1):35-9. PubMed ID: 19513502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of klotho and β-catenin in esophageal squamous cell carcinoma, and their clinicopathological and prognostic significance.
    Tang X; Fan Z; Wang Y; Ji G; Wang M; Lin J; Huang S
    Dis Esophagus; 2016 Apr; 29(3):207-14. PubMed ID: 25287007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transglutaminase 3 as a prognostic biomarker in esophageal cancer revealed by proteomics.
    Uemura N; Nakanishi Y; Kato H; Saito S; Nagino M; Hirohashi S; Kondo T
    Int J Cancer; 2009 May; 124(9):2106-15. PubMed ID: 19142970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of gamma-glutamyltransferase in patients with resectable esophageal squamous cell carcinoma.
    Yang F; Zhang S; Yang H; Luo K; Wen J; Hu Y; Hu R; Huang Q; Chen J; Fu J
    Dis Esophagus; 2015 Jul; 28(5):496-504. PubMed ID: 24766310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Prognostic Relevance of Subcarinal Lymph Node Dissection in Esophageal Squamous Cell Carcinoma.
    Niwa Y; Koike M; Hattori M; Iwata N; Takami H; Hayashi M; Tanaka C; Kobayashi D; Kanda M; Yamada S; Fujii T; Nakayama G; Sugimoto H; Fujiwara M; Kodera Y
    Ann Surg Oncol; 2016 Feb; 23(2):611-8. PubMed ID: 26289807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Lymphatic metastasis intensity of and lymphadenectomy for thoracic esophageal squamous cell carcinoma].
    Lu ZM; Zhang H; Wang MH; Cui DH; Yang YQ; Huang HZ
    Ai Zheng; 2006 May; 25(5):604-8. PubMed ID: 16687083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor budding and E-cadherin expression are useful predictors of nodal involvement in T1 esophageal squamous cell carcinoma.
    Nakagawa Y; Ohira M; Kubo N; Yamashita Y; Sakurai K; Toyokawa T; Tanaka H; Muguruma K; Shibutani M; Yamazoe S; Kimura K; Nagahara H; Amano R; Ohtani H; Yashiro M; Maeda K; Hirakawa K
    Anticancer Res; 2013 Nov; 33(11):5023-9. PubMed ID: 24222146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammation-based prognostic system predicts postoperative survival of esophageal carcinoma patients with normal preoperative serum carcinoembryonic antigen and squamous cell carcinoma antigen levels.
    Ma Q; Liu W; Jia R; Jiang F; Duan H; Lin P; Zhang L; Long H; Zhao H; Ma G
    World J Surg Oncol; 2016 May; 14():141. PubMed ID: 27151090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An expression of squamous cell carcinoma antigen 2 in peripheral blood within the different stages of esophageal carcinogenesis.
    Yang YF; Li H; Xu XQ; Diao YT; Fang XQ; Wang Y; Zhao DL; Wu K; Li HQ
    Dis Esophagus; 2008; 21(5):395-401. PubMed ID: 19125792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic and prognostic value of serum L1-cell adhesion molecule in esophageal squamous cell carcinoma.
    Xu YW; Hong CQ; Wu ZY; Peng YH; Ran LQ; Yang SH; Huang BS; Liang XY; Chen HL; Wu JY; Xu XE; Deng JW; Zou HY; Fang WK; Li EM; Xu LY; Xie JJ
    Clin Res Hepatol Gastroenterol; 2018 Dec; 42(6):597-603. PubMed ID: 30219694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T1 squamous cell carcinoma of the esophagus: long-term outcomes and prognostic factors after esophagectomy.
    Tanaka T; Matono S; Mori N; Shirouzu K; Fujita H
    Ann Surg Oncol; 2014 Mar; 21(3):932-8. PubMed ID: 24232603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoantibodies as potential biomarkers for the early detection of esophageal squamous cell carcinoma.
    Xu YW; Peng YH; Chen B; Wu ZY; Wu JY; Shen JH; Zheng CP; Wang SH; Guo HP; Li EM; Xu LY
    Am J Gastroenterol; 2014 Jan; 109(1):36-45. PubMed ID: 24296751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Explore the radiotherapeutic clinical target volume delineation for thoracic esophageal squamous cell carcinoma from the pattern of lymphatic metastases.
    Cheng J; Kong L; Huang W; Li B; Li H; Wang Z; Zhang J; Zhou T; Sun H
    J Thorac Oncol; 2013 Mar; 8(3):359-65. PubMed ID: 23263689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.